Avanos Medical, Inc. (AVNS) Stock Grade

About Avanos Medical, Inc.'s fundamentals

Avanos Medical is a $1.2 billion healthcare device company currently operating at a loss, with a net margin of -9.7% in its latest annual period. Revenue growth has been modest at 2.0% year-over-year, reflecting sluggish top-line expansion in its markets. Despite the accounting losses, the company generates positive free cash flow, indicating that its operations produce cash despite current profitability challenges. The company does not pay a dividend and lacks sufficient earnings to calculate traditional valuation metrics like P/E ratio and return on equity.